Aprogen Medicines Inc. (KRX:007460)
751.00
-1.00 (-0.13%)
Last updated: Mar 27, 2025
Aprogen Medicines Revenue
In the year 2024, Aprogen Medicines had annual revenue of 150.11B KRW, down -0.31%. Aprogen Medicines had revenue of 39.65B in the quarter ending December 31, 2024, with 6.05% growth.
Revenue
150.11B
Revenue Growth
-0.31%
P/S Ratio
1.27
Revenue / Employee
612.71M
Employees
245
Market Cap
214.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 150.11B | -464.40M | -0.31% |
Dec 31, 2023 | 150.58B | 72.23B | 92.19% |
Dec 31, 2022 | 78.35B | 52.05B | 197.95% |
Dec 31, 2021 | 26.30B | -100.85B | -79.32% |
Dec 31, 2020 | 127.14B | 48.89B | 62.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition